About two million American men undergo transrectal biopsies each year to diagnose prostate cancer or to monitor low-risk and favorable intermediate-risk prostate cancers for active surveillance (AS).
WALTHAM, Mass.--(BUSINESS WIRE)--Today Augmenix, Inc. (http://www.spaceoar.com/), a medical technology company that develops, manufactures, and sells proprietary ...
A transrectal ultrasound (TRUS) of the prostate may also be called a prostate sonogram or endorectal ultrasound. A doctor usually performs a TRUS to help diagnose prostate cancer or detect prostate ...
A multi-institutional clinical trial showed that a newer technique for collecting prostate biopsy samples reduced the risk of infection compared with traditional biopsy approaches. A ...
MADRID — For patients who undergo prostate biopsy, patient-reported adverse effects and attitudes are similar when either a transperineal approach or the more traditional transrectal approach is used, ...
Approval for this study was obtained from the Internal Review Board at our hospital. Patients referred for transrectal ultrasound from who informed consent was obtained were eligible for inclusion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results